PULMOPHARMA ApS — Credit Rating and Financial Key Figures

CVR number: 36428023
Bøgebjerg 2, 8400 Ebeltoft

Income statement (kDKK)

2020
2021
2022
2023
2024
Fiscal period length1212121212
Net sales
Gross profit-1.06-80.38-56.50-47.30-20.50
EBIT-1.06-80.38-56.50-47.30-20.50
Other financial expenses-17.90-12.72-6.33
Pre-tax profit-18.96-93.10-62.83-47.30-20.50
Net earnings-18.96-93.10-62.83-47.30-20.50

Assets (kDKK)

2020
2021
2022
2023
2024
Development expenditure73.51882.533 965.165 173.247 198.67
Intangible assets total73.51882.533 965.165 173.247 198.67
Tangible assets total
Investments total
Long term receivables total
Inventories total
Prepayments and accrued income1 598.01887.78177.562 090.25
Current other receivables5.7596.3881.6644.3819.98
Short term receivables total5.751 694.39969.44221.932 110.23
Cash and bank deposits0.361 409.6018.873 501.2216.98
Cash and cash equivalents0.361 409.6018.873 501.2216.98
Balance sheet total (assets)79.623 986.524 953.478 896.399 325.89

Equity and liabilities (kDKK)

2020
2021
2022
2023
2024
Share capital3.0040.0040.0046.6746.67
Share premium account3 963.003 963.007 956.337 956.33
Retained earnings- 379.22- 398.18- 491.29- 554.12- 601.41
Profit of the financial year-18.96-93.10-62.83-47.30-20.50
Shareholders equity total- 395.183 511.723 448.897 401.597 381.09
Non-current liabilities total
Current trade creditors7.377.3714.704.924.92
Current owed to participating467.44467.441 039.891 039.891 389.89
Other non-interest bearing current liabilities450.00450.00550.00
Current liabilities total474.80474.801 504.581 494.801 944.80
Balance sheet total (liabilities)79.623 986.524 953.478 896.399 325.89
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.